TandemAI
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $62M
Investors
- 8
About TandemAI
Based in Shanghai, China, and established in 2021, TandemAI is an innovative drug discovery that take the technology of artificial intelligence. The company has built its networked platform from the ground up in the US and China to increase the speed of drug discovery and deliver cost effective opportunities to the global scientific community. The company's co-founder is Mr. He who has more than 20 years of experience in senor business leadership roles at companies, including at most recently at HiFiBiO, where he served as co-founder and COO, and Harbour BioMed, where he was a co-founder and CFO., who served at Merck in several senior research roles, with his latest position as a Distinguished Senior Investigator. The company provides new drug discovery service. The company developed proprietary AI-driven, high-performance computational platform with wet labs for biophysics, medicinal chemistry, and biology in order to accelerate the design and optimization of drug candidates for partners. The company plans to advance the company's proprietary and computational platform and support expansion of wet lab capacity.
Who invested in TandemAI
8 investors across 3 rounds
See all investors in TandemAI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TandemAI
Who invested in TandemAI?
TandemAI has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TandemAI raised?
TandemAI has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did TandemAI last raise money?
TandemAI's most recent round on record is a Series A, in Nov 2025.
What does TandemAI do?
Based in Shanghai, China, and established in 2021, TandemAI is an innovative drug discovery that take the technology of artificial intelligence.
Where is TandemAI headquartered?
TandemAI is headquartered in Shanghai, China.
Which VCs invest in companies like TandemAI?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at TandemAI's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like TandemAI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.